Commonwealth Equity Services, LLC Adaptive Biotechnologies Corp Transaction History

Commonwealth Equity Services, LLC

$63.2 Billion
Q2 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 45,628 shares of ADPT stock, worth $210,345. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,628

Previous 45,961 0.72%

Holding current value

$210,345

Previous $148,000 11.49%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$2.34 - $3.96 $779 - $1,318	-333 Reduced 0.72%	45,628 $165,000
Q1 2024 Apr 29, 2024	SELL	$2.88 - $4.8 $941 - $1,569	-327 Reduced 0.71%	45,961 $148,000
Q4 2023 Feb 06, 2024	SELL	$3.46 - $5.33 $31,056 - $47,842	-8,976 Reduced 16.24%	46,288 $227,000
Q3 2023 Oct 23, 2023	BUY	$5.07 - $8.44 $17,734 - $29,523	3,498 Added 6.76%	55,264 $301,000
Q2 2023 Aug 10, 2023	BUY	$6.19 - $8.78 $11,142 - $15,803	1,800 Added 3.6%	51,766 $347,000
Q1 2023 May 11, 2023	SELL	$7.8 - $10.11 $39,273 - $50,903	-5,035 Reduced 9.15%	49,966 $441,000
Q4 2022 Feb 07, 2023	BUY	$6.26 - $9.34 $8,138 - $12,142	1,300 Added 2.42%	55,001 $420,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $7,962 - $15,520	1,225 Added 2.33%	53,701 $382,000
Q2 2022 Jul 19, 2022	SELL	$6.4 - $14.73 $8,896 - $20,474	-1,390 Reduced 2.58%	52,476 $424,000
Q1 2022 May 04, 2022	BUY	$10.12 - $28.9 $67,814 - $193,658	6,701 Added 14.21%	53,866 $747,000
Q4 2021 Jan 31, 2022	SELL	$25.17 - $36.85 $375,058 - $549,101	-14,901 Reduced 24.01%	47,165 $1.32 Million
Q3 2021 Oct 29, 2021	SELL	$30.02 - $39.87 $82,344 - $109,363	-2,743 Reduced 4.23%	62,066 $2.11 Million
Q2 2021 Aug 11, 2021	BUY	$32.22 - $44.59 $729,879 - $1.01 Million	22,653 Added 53.74%	64,809 $2.65 Million
Q1 2021 May 04, 2021	SELL	$37.26 - $67.74 $8,383 - $15,241	-225 Reduced 0.53%	42,156 $1.7 Million
Q4 2020 Feb 11, 2021	SELL	$45.01 - $65.47 $40,238 - $58,530	-894 Reduced 2.07%	42,381 $2.51 Million
Q3 2020 Nov 05, 2020	BUY	$35.79 - $48.81 $39,941 - $54,471	1,116 Added 2.65%	43,275 $2.1 Million
Q2 2020 Aug 12, 2020	BUY	$24.95 - $48.38 $898 - $1,741	36 Added 0.09%	42,159 $2.04 Million
Q1 2020 May 11, 2020	BUY	$16.96 - $34.16 $714,406 - $1.44 Million	42,123 New	42,123 $1.17 Million

Others Institutions Holding ADPT

# of Institutions

187

Shares Held

152M

Call Options Held

8.4K

Put Options Held

56K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $659M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Adaptive Biotechnologies Corp Transaction History